Alumis Inc.
Ticker: ALMS
| Insider | Title |
|---|---|
| Alan Colowick | Director |
| Capital Fund V, L.p. Foresite | 10% or greater ownership |
| Capital Fund Vi Lp Foresite | 10% or greater ownership |
| Capital Management Company, Lp Ayurmaya | Director, See Remarks, 10% or greater ownership |
| Capital Management V, Llc Foresite | 10% or greater ownership |
| Capital Management Vi Llc Foresite | 10% or greater ownership |
| Capital Opportunity Fund V, L.p. Foresite | 10% or greater ownership |
| Capital Opportunity Management V, Llc Foresite | 10% or greater ownership |
| Co-invest V, Llc Labs | 10% or greater ownership |
| David E. Goel | Director, See Remarks, 10% or greater ownership |
| David M Goldstein | Chief Scientific Officer |
| Derrick Richardson | SVP, People and Culture |
| James B. Tananbaum | Director, 10% or greater ownership |
| John R. Schroer | Chief Financial Officer |
| Jorn Drappa | Chief Medical Officer |
| Labs Affiliates 2021, Llc Foresite | 10% or greater ownership |
| Labs Fund I, L.p. Foresite | 10% or greater ownership |
| Labs Management I, Llc Foresite | 10% or greater ownership |
| Labs, Llc Foresite | 10% or greater ownership |
| Mark Christopher Bradley | Chief Development Officer |
| Martin Babler | President, CEO and Chairman, Director |
| Patrick Machado | Director |
| Roy C. Hardiman | Chief Business Legal Officer |
| Sapna Srivastava | Director |
| Sara Klein | General Counsel - Corp Secy |
| Srinivas Akkaraju | Director |
| Zhengbin Yao | Director |